Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Unlimited Watchlists, Portfolios, Screeners, and other Barchart tools. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Pliant Therapeutics Inc (PLRX)

Pliant Therapeutics Inc (PLRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 896,190
  • Shares Outstanding, K 48,759
  • Annual Sales, $ 7,570 K
  • Annual Income, $ -97,260 K
  • 60-Month Beta 1.26
  • Price/Sales 125.70
  • Price/Cash Flow N/A
  • Price/Book 2.82
Trade PLRX with:

Options Overview Details

View History
  • Implied Volatility 90.12% ( -0.12%)
  • Historical Volatility 50.70%
  • IV Percentile 64%
  • IV Rank 25.04%
  • IV High 219.00% on 06/29/22
  • IV Low 47.07% on 05/12/22
  • Put/Call Vol Ratio 0.07
  • Today's Volume 60
  • Volume Avg (30-Day) 51
  • Put/Call OI Ratio 0.64
  • Today's Open Interest 3,001
  • Open Int (30-Day) 2,899

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.71
  • Number of Estimates 5
  • High Estimate -0.68
  • Low Estimate -0.74
  • Prior Year -0.68
  • Growth Rate Est. (year over year) -4.41%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.50 +5.03%
on 11/30/22
25.49 -27.88%
on 11/01/22
-6.64 (-26.54%)
since 10/28/22
3-Month
17.50 +5.03%
on 11/30/22
26.25 -29.98%
on 10/25/22
+0.27 (+1.49%)
since 08/30/22
52-Week
3.96 +363.56%
on 05/11/22
26.25 -29.98%
on 10/25/22
+3.89 (+26.85%)
since 11/26/21

Most Recent Stories

More News
Pliant Therapeutics, Inc. (PLRX) Reports Q3 Loss, Misses Revenue Estimates

Pliant Therapeutics, Inc. (PLRX) delivered earnings and revenue surprises of 12.16% and 34.43%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the...

PLRX : 18.38 (-5.84%)
SPRO : 1.9100 (-1.55%)
Codexis (CDXS) Reports Q3 Loss, Tops Revenue Estimates

Codexis (CDXS) delivered earnings and revenue surprises of 16.67% and 9.74%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

CDXS : 5.47 (+8.75%)
PLRX : 18.38 (-5.84%)
Is Assertio (ASRT) Stock Outpacing Its Medical Peers This Year?

Here is how Assertio (ASRT) and Pliant Therapeutics, Inc. (PLRX) have performed compared to their sector so far this year.

ASRT : 3.15 (+1.56%)
PLRX : 18.38 (-5.84%)
3 Soaring Biotech Stocks That Could Climb Much Higher

These drugmakers have bucked the overall market's downward trend this year and expectations are still high.

BLTE : 32.77 (-0.64%)
CINC : 11.63 (-1.44%)
PLRX : 18.38 (-5.84%)
AVEO Pharmaceuticals (AVEO) Inks Deal to be Acquired by LG Chem

Aveo Pharmaceuticals (AVEO) is set to be acquired by LG Chem for an aggregate amount of $566 billion. The deal is expected to close by early 2023. Stock up.

BMRN : 90.00 (-10.87%)
AVEO : 14.94 (-0.07%)
ACAD : 15.58 (+6.20%)
PLRX : 18.38 (-5.84%)
Milestone's (MIST) Tachycardia Study Data Fail to Impress Investors

Milestone (MIST) reports positive top-line results from its late-stage study evaluating its lead candidate, etripamil, in patients with paroxysmal supraventricular tachycardia. The results fail to impress...

BMRN : 90.00 (-10.87%)
ACAD : 15.58 (+6.20%)
MIST : 4.91 (-0.20%)
PLRX : 18.38 (-5.84%)
Emergent (EBS) Initiates Study on Lassa Virus Vaccine Candidate

Emergent BioSolutions (EBS) initiates an early-stage study evaluating its Lassa virus vaccine candidate, EBS-LASV, for the prevention of Lassa fever.

MRK : 109.76 (-0.33%)
EBS : 12.30 (unch)
INO : 2.00 (-1.96%)
PLRX : 18.38 (-5.84%)
Axsome (AXSM) up 118.4% in the Past Three Months: Here's Why

Axsome (AXSM) surges in the past three months owing to its Sunosi acquisition and promising progress on its pipeline candidate.

JAZZ : 156.91 (+0.81%)
AXSM : 72.94 (+0.91%)
SESN : 0.5600 (+1.12%)
PLRX : 18.38 (-5.84%)
Has Pliant Therapeutics (PLRX) Outpaced Other Medical Stocks This Year?

Here is how Pliant Therapeutics, Inc. (PLRX) and Alaunos (TCRT) have performed compared to their sector so far this year.

PLRX : 18.38 (-5.84%)
TCRT : 0.6700 (+5.02%)
Pliant Therapeutics, Inc. (PLRX) Upgraded to Buy: What Does It Mean for the Stock?

Pliant Therapeutics, Inc. (PLRX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

PLRX : 18.38 (-5.84%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Pliant Therapeutics Inc. is a clinical stage biopharmaceutical company. It is focused on discovering and developing novel therapies for the treatment of fibrosis. The company's lead product consist PLN-74809 and PLN-1474 which are in clinical stage. Pliant Therapeutics Inc. is based in SAN FRANCISCO,...

See More

Key Turning Points

3rd Resistance Point 21.55
2nd Resistance Point 20.57
1st Resistance Point 19.47
Last Price 18.38
1st Support Level 17.39
2nd Support Level 16.41
3rd Support Level 15.31

See More

52-Week High 26.25
Last Price 18.38
Fibonacci 61.8% 17.74
Fibonacci 50% 15.11
Fibonacci 38.2% 12.48
52-Week Low 3.96

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar